h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
USTCi001-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
USTCi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
USTCi001-A (RRID:CVCL_ZE23)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
27th April 2020
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
School of Life Sciences, University of Science and Technology of China (USTC)
External Databases
Cellosaurus
CVCL_ZE23
Wikidata
Q98134372
General Information
Publications
Zhao H et al. Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy. Stem cell research. 2020 May;45:101785.
Zhao H et al. Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene. Stem cell research. 2020 Jul;46:101864.
Zhao H et al. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing. Stem cell research. 2020 Oct;48:102003.
Zhao H et al. A heterozygous SCN1A (c.A5768G/+) mutant human induced pluripotent stem cell line (USTCi002-A) generated using TALEN-mediated precise gene editing. Stem cell research. 2020 Dec;49:102058.
Khorkova O et al. Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent Developments. Frontiers in molecular biosciences. 2021;8:643681.
Tahbaz M et al. Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes. Frontiers in endocrinology. 2021;12:716625.
Zhao H et al. Ameliorating Effect of Umbilical Cord Mesenchymal Stem Cells in a Human Induced Pluripotent Stem Cell Model of Dravet Syndrome. Molecular neurobiology. 2022 Feb;59(2):748-761.
Zayat V et al. Concise Review: Stem Cell Models of SCN1A-Related Encephalopathies-Current Perspective and Future Therapies. Cells. 2022 Oct 4;11(19).
Javaid MS et al. Human In Vitro Models of Epilepsy Using Embryonic and Induced Pluripotent Stem Cells. Cells. 2022 Dec 7;11(24).
Shtykalova Sofia et al. Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications. Life. 2023-03-29.
Sharma Rakesh. Innovative Genoceuticals in Human Gene Therapy Solutions: Challenges and Safe Clinical Trials of Orphan Gene Therapy Products. Current Gene Therapy. 2024-02-00.
Gao Jingjing et al. Gene therapy for CNS disorders: modalities, delivery and translational challenges. Nature Reviews Neuroscience. 2024-08-00.
Khatun Munzura et al. Isolation, Purification, and Characterization of Endochitinase Producing Bacteria as Potential Bio-control Agents of Fungal Phytopathogens. Natural Product Communications. 2025-06-00.
Subclones
USTCi001-A-1
USTCi001-A-2
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.